IDM Insight: £1M Round A investment

IDM Insight is a UK-based clinical research technology company using AI to cut the time and cost of drug development — an industry where the average trial runs $1–2.6B, only ~10% of Phase I candidates reach approval, and 80% of trials hit recruitment delays. Its flagship platform, ClinCraft, runs AI-driven trial simulations that convert a study's specifications into an optimized protocol — streamlining trial design, anticipating regulatory obstacles, and improving recruitment of underrepresented populations, with average time savings of up to nine months. Built in partnership with AWS and NVIDIA and led by a team drawn from IQVIA, Clarivate, and Sygnature Discovery, IDM Insight targets a $260B addressable market growing at up to ~43% CAGR in pharmaceutical AI. With early traction across biotech and CRO customers and partner-accelerator backing from AWS and NVIDIA, the company is now raising a £1M Round A (UK SEIS/EIS).